Trials / Conditions / Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
3 registered clinical trials studyying Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS).
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Crossover Study to Assess the Efficacy and Safety of UX007 in the Treatment of Movement Disorders Associated W NCT02960217 | Ultragenyx Pharmaceutical Inc | Phase 3 |
| Completed | Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glu NCT01993186 | Ultragenyx Pharmaceutical Inc | Phase 2 |
| Completed | An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome NCT02036853 | Adrian Lacy | Phase 2 |